中华放射肿瘤学杂志
  Home | Journal | Editorial | Instruction | Subscription | Advertisement | Academic | Index-in | Contact Us | Chinese
中华放射肿瘤学杂志
  Office  
 

Journal

 
   Forthcoming Articles
   Current Issue
   Next Issue
   Advanced Search
   Archive
   Download Articles
   Read Articles
   Email Alert
   RSS
  Download  
   Instruction
   Template
   Copyright Agreement
          More  
 
Quick Search  
  Advanced Search
Chinese Journal of Radiation Oncology
 
2018 Vol.27 Issue.5
Published 2018-05-15

Head and Neck Tumors
Abdominal Tumors
Thoracic Tumors
Physics·Biology·Technique
Review Articles
Symposium
Head and Neck Tumors
435 Whole-brain irradiation with simultaneous integrated boost by helical tomotherapy for multiple brain metastases:dosimetric and clinical analyses
Ma Yuchao, Xiao Jianping, Bi Nan, Xu Yingjie, Tian Yuan, Zhang Hongmei, Zhang Ye, Liu Qingfeng, Deng Lei, Wang Wenqing, Zhao Ruizhi, Yang Siran, Yi Junlin, Li Yexiong
Objective To retrospectively analyze the dosimetry and efficacy of whole-brain irradiation (WBRT) with simultaneous integrated boost (SIB) by helical tomotherapy (HT) in the treatment of multiple brain metastases (BMs), and to evaluate the feasibility, efficacy, and safety of HT. Methods From 2014 to 2017, a total of 43 patients with multiple BMs (no less than 3 lesions) were enrolled as subjects. A dose of 40 Gy was delivered to the whole brain in 20 fractions, while a dose of 60 Gy was delivered to the gross target volume (GTV) in 20 fractions. Patients were reexamined by magnetic resonance imaging during treatment. The radiation field would be shrunk if GTV was reduced. Target coverage (TC), conformity index (CI), prescription isodose/target volume (PITV) ratio , and homogeneity index (HI) were assessed. Clinical indices included local recurrence-free survival (LRFS), intracranial progression-free survival (IPFS), progression-free survival (PFS), overall survival (OS), and toxicities. Results The median lesion number was 6(3-36) and the median total volume of GTV was 8.74 cm3. The TC, CI, PITV, and HI for GTV were 0.96±0.028, 0.51±0.164, 2.09±1.245, and 0.12±0.066, respectively, while the TC and HI for the whole brain were 0.95±0.033 and 0.43±0.161, respectively. In all the patients, 26% had replanning during treatment. The two-stage treatment reduced the radiation dose to organs at risk. The 1-year LRFS, IPFS, PFS, and OS rates were 96%, 80%, 39%, and 86%, respectively. No grade ≥3 toxicities were observed. Conclusions WBRT with SIB by HT achieves satisfactory conformity, homogeneity, efficacy, and safety, which is a recommended treatment plan for multiple BMs. Replanning during treatment can better protect normal tissue.
2018 Vol. 27 (5): 435-440 [Abstract] ( 1110 ) [HTML 1KB] [ PDF 0KB] ( 0 )
441 Analysis of risk factors of outcomes of radiation induced-brain injury after IMRT in nasopharyngeal carcinoma
Wang Hongzhi, Wang Kai, Qu Yuan, Zhang Shiping, Huang Xiaodong, Yi Junlin, Xiao Jianping, Li Suyan, Gao Li, Xu Guozhen, Luo Jingwei
Objective To explore the risk factors influencing the outcomes of radiation brain injury after intensity-modulated radiotherapy (IMRT) in patients diagnosed with nasopharyngeal carcinoma. Methods Clinical data of 1300 nasopharyngeal carcinoma patients treated with IMRT in our hospital during 2006 and 2013 were retrospectively analyzed. Fifty-eight patients presented with radiation brain injury after IMRT. MRI data of these patients during 3-24 months follow-up were collected. The clinical efficacy in the treatment of radiation brain injury was evaluated according to RECIST guidelines. Results Forty-six patients with intact follow-up data were enrolled. The median latency of radiation brain injury was 34 months. Patients were divided into the response (CR+PR) and non-response groups. The risk factors influencing the response rate during 10-12 months and 18-24 months were identified and analyzed. Univariate analysis demonstrated that gender, age, smoking history, T stage, and high-intensity treatment exerted no significant effect upon the Objective remission rate during these two time intervals periods. Patients treated with gangliosides obtained high response rate. The response rate was 68.8% in 10-12 months (P=0.000),and 81.8% in 18-24 months (P=0.008).Multivariate analysis revealed that use of gangliosides was a favorable factor for mitigating radiation brain injury in two time intervals (OR=19.8 and 13.5;P=0.001 and 0.005). Conclusions Use of gangliosides probably accelerates the healing of radiation brain injury, whereas the clinical efficacy remains to be elucidated by prospective clinical trials.
2018 Vol. 27 (5): 441-444 [Abstract] ( 1088 ) [HTML 1KB] [ PDF 0KB] ( 0 )
445 A preliminary study of the protection of bone marrow in craniospinal irradiation
Chen Shan, Li Rongqing
Objective To analyze the relationship between the dose volume of bone marrow and acute hematologic toxicity in craniospinal irradiation (CSI),and preliminarily explore the dosimetric differences in bone marrow between helical tomotherapy (HT) and volumetric modulated arc therapy (VMAT). Methods Clinical data and HT plans of twenty patients treated with CSI in the First Affiliated Hospital of Kunming Medical University were collected, and the HT plans were transferred back to the MIM system. The skull, mandible, clavicle, sternum, scapula, ribs, vertebrae and pelvis were successively delineated on the CT images and then the V2,V5,V10,V15,V20,V25,V30,V35,Dmax,Dmean of each aforementioned bone and total bone were read on DVH images. The correlation between those indexes and the incidence of ≥grade Ⅱ hematologic toxicity was subsequently analyzed. The images of 6 patients were selected and transferred to Monaco TPS and VMAT plans were completed. The dosimetric differences of those indexes were statistically compared between HT and VMAT. Statistical analyses were performed by using Spearman correlation analysis and Wilcoxon symbol rank-sum test. Results The incidence of ≥grade Ⅱ leukopenia was positively correlated with the V25 of pelvis and the V5 of total bones (P=0.038);the risk of ≥ grade Ⅱ thrombocytopenia was positive associated with the V20 of pelvis (P=0.041);the incidence of ≥ grade Ⅱ neutropenia was positively correlated with the V10 of vertebrae (P=0.036). There was no dosimetric difference of dose volume of vertebral and pelvis between HT and VMAT plans (P>0.05). Conclusions There is a positive correlation between ≥ grade Ⅱ leukopenia and the V25 of pelvis and the V5 of total bones. The V20 of pelvis shows a positive correlation with ≥ grade Ⅱ thrombocytopenia. A positive correlation is found between ≥ grade Ⅱ neutropenia and the V10 of vertebrae. The indices of vertebral and pelvis between HT and VMAT plans show no significant differences.
2018 Vol. 27 (5): 445-448 [Abstract] ( 1081 ) [HTML 1KB] [ PDF 0KB] ( 0 )
Thoracic Tumors
449 Clinical application of barium radiography and computed tomography-based short-term outcome evaluation criteria in esophageal cancer
Ren Xuejiao, Wang Lan, Chen Liying, Han Chun, Ding Boyue, Liu Lihong, Liu Shutang, Li Xiaoning, Gao Chao, Xu Liang
Objective To explore and improve the feasibility and prognostic value of barium radiography and computed tomography (CT)-based evaluation criteria in evaluation of the short-term efficacy of radiotherapy for esophageal cancer, and to provide a basis for clinical application. Methods The short-term treatment outcomes of 529 patients with esophageal carcinoma receiving three-dimensional radiotherapy from 2004 to 2015 were evaluated by the 2013 version of barium radiography and CT-based evaluation criteria. The local control (LC) and survival rates were calculated using the Kaplan-Meier method. The log-rank test was used for data analysis and univariate prognostic analysis. The agreement between two evaluation criteria was measured by the Kappa coefficient. Results According to the results of the survival analysis in all the patients using the evaluation criteria for short-term treatment outcomes, the 3-, 5-, 7-, and 9-year LC rates were 78.6%, 69.8%, 69.8%, and 63.4% in the complete response (CR) group (n=52), and 56.4%, 47.9%, 46.2%, and 42.4% in the partial response (PR) group (n=409), respectively;the 3-, 5-, 7-, and 9-year overall survival (OS) rates were 62.7%, 49.1%, 39.8%, and 39.8% in the CR group, and 29.5%, 21.6%, 20.6%, and 19.5% in the PR group, respectively;the median OS time was 50, 17, and 5 months in the CR group, PR group, and non-response group (n=12), respectively (P=0.000). According to CT measurements, the short diameter of residual metastatic lymph node after radiotherapy was between 0.37-3.40 cm (median value=0.82 cm). All patients were divided into groups based on the short diameter of residual metastatic lymph node after radiotherapy with a gradient of 0.5 cm. Patients with short diameters of residual metastatic lymph node of ≤1.00 cm had a significantly higher OS rate than those with short diameters of residual metastatic lymph node of>1.00 cm (P=0.000). The lymph node volume of 1.00 cm3 in the original criteria was replaced by the short diameter of residual metastatic lymph node of 1.00 cm after radiotherapy and treatment outcomes were re-evaluated using the new criteria. The CR group still had significantly higher LC and OS rates than the PR group (P=0.000). There was a good agreement between the two evaluation criteria (Kappa=0.863). Conclusions The barium radiography and CT-based evaluation criteria for short-term treatment outcomes can accurately evaluate the short-term outcomes and predict prognosis in patients with esophageal carcinoma. Replacing the volume in the original criteria with the short diameter of residual metastatic lymph node after radiotherapy achieves similar results in prognostic prediction.
2018 Vol. 27 (5): 449-454 [Abstract] ( 1456 ) [HTML 1KB] [ PDF 0KB] ( 0 )
455 Value of positive lymph node metastasis region in predicting postoperative recurrence for patients with esophageal squamous cell carcinoma after two-field esophagectomy
Wang Yuxiang, Yang Qiong, He Ming, Oiu Rong, Qi Zhan, Yang Jie, Zhu Shuchai, Qiao Xueying
Objective The recurrence rate is alarmingly high in patients with positive lymph node metastasis (pN+) esophageal squamous cell carcinoma (ESCC) after two-field surgery. This study aims to retrospectively evaluate the value of pN+ region in predicting postoperative recurrence in patients with pN+ thoracic ESCC after two-field radical esophagectomy. Methods A total of 329 patients with pN+ thoracic ESCC after two-field R0 esophagectomy were enrolled in this study. After surgery,pN+ region was located at the upper abdomen in 116 patients,mediastinum in 119 and upper abdomen plus mediastinum in 94, respectively. The enumeration data were analyzed by chi-square test. Logistic multivariate regression analysis was performed to evaluate the risk factors of postoperative recurrence. Cumulative recurrence rate was statistically analyzed by using Kaplan-Meier method, Log-rank test and Cox model multivariate analysis. Results The overall recurrence rate was 72.4%(239/329).The overall locoregional recurrence (LR) rate was 58.1%(139/329) including 14.6% in the neck,42.9% in the mediastinum and 10.0% in the upper abdomen. Multivariate logistic and Cox regression analyses demonstrated that pN+ region was the only independent factor affecting the overall recurrence and LR rates (both P<0.05).The overall recurrence and LR rates were 57.8% and 44.0% for patients with pN+ region in the upper abdomen,77.3% and 62.3% for those with pN+ region in the mediastinum and 85.1% and 72.3% for their counterparts with pN+ region in the upper abdomen and mediastinum,respectively. Additionally pN+ region was also the independent factor of the recurrence in the mediastinum or upper abdomen (both P<0.05) rather than the neck (P>0.05).The recurrence rates in the mediastimun and upper abomen were 27.6% and 12.9% for patients with pN+ region in upper abdomen,47.1% and 4.2% for those with pN+ region in the mediastinum,and 56.4% and 13.8% for patients with pN+ region in the upper-abdomen plus mediastinum,respectively. Conclusions LR is the main cause of failure in patients with pN+ thoracic ESCC after two-field R0 surgery.pN+ region can be utilized to predict the overall recurrence and LR rates,especially for patients with postoperative recurrence in the the mediastinum and upper abdomen. The findings in this investigation contribute to the design of the target volume of postoperative adjuvant radiotherapy.
2018 Vol. 27 (5): 455-462 [Abstract] ( 933 ) [HTML 1KB] [ PDF 0KB] ( 0 )
463 Clinical efficacy of erlotinib combined with concurrent whole brain radiotherapy in treatment of multiple brain metastases from EGFR-mutant lung adenocarcinoma
Sun Di, Zhang Sheng, Lin Guangyong, Zhang Youting
Objective To investigate the clinical efficacy and safety of erlotinib combined with concurrent whole brain radiotherapy (WBRT) in the treatment of multiple brain metastases from lung adenocarcinoma, and to provide Objective evidence for improving the prognosis of patients. Methods Eighty-nine patients with brain metastases from epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma who were admitted to our hospital were divided into experimental group (n=45) and control group (n=44) according to the different treatment methods. The experimental group received erlotinib combined with concurrent WBRT. The control group received oral administration of erlotinib alone for 28 d and then received concurrent WBRT. The survival rates were calculated using the Kaplan-Meier method and analyzed using the log-rank test. The other data were analyzed by the chi-square test. Results The Objective response rate was significantly higher in the experimental group than in the control group (78% vs. 55%, P=0.000). The median progression-free survival (PFS) time in the experimental group and the control group were 9.1 months (95% confidence interval[CI]:5.18-12.47) and 5.6 months (95%CI:3.46-9.12), respectively (P=0.078). The median overall survival (OS) time in the experimental group and the control group were 14.3 months (95%CI:9.51-17.82) and 9.7 months (95%CI:4.59-16.74), respectively (P=0.032). The incidence rates of headache and dizziness were significantly higher in the experimental group than in the control group (38% vs. 14%, P=0.029;33% vs. 9%, P=0.020). Conclusions In the treatment of multiple brain metastases from EGFR-mutant lung adenocarcinoma, erlotinib combined with concurrent WBRT is superior to erlotinib alone. The combination therapy increases PFS and OS time of the nervous system in patients.
2018 Vol. 27 (5): 463-466 [Abstract] ( 1352 ) [HTML 1KB] [ PDF 0KB] ( 0 )
Abdominal Tumors
467 Neoadjuvant rectal score in prognostic prediction of clinical stage Ⅲ middle-low rectal cancer
Li Shuai, Jin Jing, Ye feng, Tang yuan, Li Ning, Yu Jing, Ren Hua, Wang Xin, LiuWen Yang, Wang Shulian, Song Yongwen, Wang Weihu, Liu Yueping, Fang Hui, Lu Ning Ning, Tang Yu, Chen Bo, Li Yexiong
Objective To investigate the effects of downstaging and neoadjuvant rectal (NAR) score on the prognosis of patients with clinical stage Ⅲ middle-low rectal cancer undergoing preoperative concurrent chemoradiotherapy. Methods From 2006 to 2014, 195 patients who were admitted to our hospital and diagnosed with clinical stage Ⅲ middle-low rectal cancer by pelvic magnetic resonance imaging or computed tomography were enrolled. All patients received preoperative radiotherapy with doses of 42-50.4 Gy (median:50 Gy, 93.8% of patients received doses of ≥50 Gy) and concurrent chemotherapy with capecitabine ± oxaliplatin. Total mesorectal (R0) excision surgery was performed at 4-15 weeks (median:7 weeks) after concurrent chemoradiotherapy. The effects of downstaging (stage yp0—Ⅱ) and NAR score (calculated based on cT staging and ypT/N staging) on the prognosis were evaluated. The 3-year disease-free survival (DFS) rate was calculated using the Kaplan-Meier method and analyzed by log-rank test. Results In all the patients, the median follow-up time was 44 months (6.7-125.5 months);the 3-year DFS rate was 76.8%. Downstaging after preoperative chemoradiotherapy was a significant prognostic factor for the 3-year DFS (92.2% vs. 56.8%, P=0.000). The median NAR score was 15.0(0-65.0) in all the patients. Patients with NAR scores of ≤15.0 had significantly improved 3-year DFS than those with NAR scores of>15.0(90.1% vs. 57.0%, P=0.001). In patients with downstaging, those with NAR scores of ≤8.4 had significantly improved prognosis compared with those with NAR scores of>8.4(95.1% vs. 87.5%, P=0.022). Conclusions Patients with downstaging after preoperative concurrent chemoradiotherapy for stage cⅢ middle-low rectal cancer have satisfactory prognosis. The NAR score is an effective prognostic predictor.
2018 Vol. 27 (5): 467-472 [Abstract] ( 1172 ) [HTML 1KB] [ PDF 0KB] ( 0 )
473 A comparative clinical study of postoperative intensity-modulated radiotherapy combined with concurrent and sequential chemotherapy for high-risk early-stage cervical cancer
Nie Fangfang, Wang Li-hua, Teng Yin-cheng, Wang Yu-dong, Fu Jie
Objective To evaluate the efficacy and acute toxicities of postoperative intensity-modulated radiotherapy (IMRT) combined with concurrent (C-IMRCT) or sequential chemotherapy (S-IMRCT) in the treatment of high-risk early-stage cervical cancer. Methods A retrospective study was performed on the clinical data of 105 patients with high-risk early-stage (ⅠB1-ⅡA2) cervical cancer from 2009 to 2017. Those patients were divided into C-IMRCT group (n=73) and S-IMRCT group (n=32). The 5-year disease-free survival (DFS) and overall survival (OS) rates, recurrence rate, metastasis rate, and acute toxicities were compared between the two groups. The survival rates were calculated by the Kaplan-Meier method and analyzed by the log-rank test. Univariate prognostic analysis was performed by the log-rank test. Recurrence, metastasis, and adverse reactions were compared using continuous correction chi-square test. Results The median follow-up time was 20 and 23 months in the C-IMRCT group and the S-IMRCT group, respectively (P=0.813). There were no significant differences in the 5-year DFS and OS rates between the two groups (72.6% vs. 72.5%, P=0.918;82.8% vs. 78.5%, P=0.504). There were no significant differences in the recurrence and metastasis rates between the two groups (P=0.598;P=1.000). The univariate prognostic analysis showed that no pathological factor affected prognosis. There were no significant differences in the incidence rates of grade 1-2 hematological toxicity, diarrhea, and urinary tract infection between the two groups (46.6% vs. 41.9%, P=0.884;P=0.854;P=0.271). Conclusions Further clinical studies are needed in terms of the survival rate in patients with high-risk early-stage cervical cancer receiving C-IMRCT.
2018 Vol. 27 (5): 473-477 [Abstract] ( 1082 ) [HTML 1KB] [ PDF 0KB] ( 0 )
478 Short-term efficacy of iodine-125 radioactive seed implantation therapy for hypoxic tumors
Zheng Bao, Shi Jingbin, Song Chenghui, Lei Hongwei, Zhao Yan, Li Hongye, Ye Fuxiu1, Ma Yuhong, Zou Lijuan, Zhang Haichen
Objective To study the short-term efficacy of computed tomography (CT)-guided iodine-125(125I) radioactive seed implantation in the treatment of hypoxic tumors. Methods Twenty-two patients treated with 125I radioactive seed implantation in our department from 2014 to 2016 were divided into hypovascular tumor group (hypoxic group,n=12) and hypervascular tumor group (non-hypoxic group,n=10) based on the hemodynamics of solid tumor evaluated by color Doppler ultrasound. The enhanced CT images were loaded to the three-dimensional particle implantation planning system for preoperative planning. After 125I radioactive seed implantation,the D90 for target volume was verified to be 106-128 cGy. Treatment outcomes were evaluated according to the World Health Organization criteria at 1-3 months after surgery. Results In all the patients, the overall response rate was 82% at 3 months after surgery. There were no significant differences in response (complete response+ partial response) rates at 1, 2, or 3 months after surgery between the hypoxic group and the non-hypoxic group (P=0.840, 0.696, 0.840). Conclusions In the treatment of solid malignant tumor, 125I radioactive seed implantation can overcome the resistance of hypoxic tumor to radiotherapy in vitro and achieve satisfactory short-term efficacy.
2018 Vol. 27 (5): 478-482 [Abstract] ( 976 ) [HTML 1KB] [ PDF 0KB] ( 0 )
Physics·Biology·Technique
483 Impacts of patient factors on intensity-modulated radiotherapy planning after breast-conserving surgery for breast cancer
Wang Yong, Wu Bo, Ying Shenpeng, Chen Weijun, Ni Lingqin, Hu Wei
Objective To investigate the impacts of planning target volume (VPTV), maximal heart distance (MHD), central lung distance (CLD), and cardiothoracic ratio (CTR) on intensity-modulated radiotherapy (IMRT) after breast-conserving surgery for breast cancer. Methods Forty-eight patients with breast cancer (31 with left-sided breast cancer and 17 with right-sided breast cancer) who received whole-breast IMRT after breast-conserving surgery in our hospital from 2016 to 2017 were enrolled as subjects. The prescribed radiation dose for PTV was 50 Gy in 25 fractions. In IMRT planning for each patient, the Objective function was optimized using physical parameters and the equivalent uniform dose. The relationship of influencing factors with dose-volume histogram, conformal index (CI), and homogeneity index (HI) for organ at risk was predicted using univariate and multivariate linear regression analyses. Results CTR and VPTV were independent influencing factors for CI in patients with left-sided breast cancer (R2=0.56, P=0.04;R2=0.56, P=0.00). CLD was an independent influencing factor for HI in patients with left-sided breast cancer (R2=0.17, P=0.023). VPTV was an independent influencing factor for CI in patients with right-sided breast cancer (R2=0.48, P=0.00). MHD and CTR were predictors for VHeart30 of the heart. MHD and CLD were predictors for DmaxHeart of the heart. The prediction formulae for left-sided breast cancer were CI=0.38+0.32CTR and HI=1.06+0.02CLD. CI was 0.48 at the right side. At the left side, Vlung20=12.68+3.18CLD, Vlung10=18.78+4.3CLD, Vlung5=26.2+5.2CLD, and Dmeanlung=686.7+210.1CLD. For the heart, VHeart30=-13.65+30.5CTR+1.9MHD and DmaxHeart=5140.1+248.9MHD-195.6CLD. There was no correlation of patient′s heart volume with MHD, VHeart10, VHeart5, DmeanHeart, or DmaxHeart. There was no correlation of whole lung volume with CLD, Vlung20, Vlung10, Vlung5, or Dmeanlung. The mean values of CI and HI were 0.63±0.06(0.46-0.72) and 1.09±0.02(1.07-1.14) in radiotherapy plans for left-sided breast cancer, and 0.65±0.08(0.48-0.76) and 1.09±0.04(1.03-1.18) in radiotherapy plans for right-sided breast cancer, respectively. Conclusions CTR, CLD, and MHD can predict the rationality of each parameter in IMRT planning for left-sided breast cancer rather than right-sided breast cancer. The obtained formulae can help physicians choose the optimal setting mode for radiation field and improve the quality of treatment plans.
2018 Vol. 27 (5): 483-488 [Abstract] ( 1070 ) [HTML 1KB] [ PDF 0KB] ( 0 )
489 Influence of MRI-CT fusion image on gross tumor volume delineation and dose distribution for radiation of primary tumors of cervical vertebra
Jiang Ping, Meng Na, Wang Junjie, Zhang Xile, Sun Haitao, Jiang Weijuan, Li Feng
Objective To compare the differences of gross tumor volume (GTV) and dose distribution between MRI-CT fusion imaging and CT-based imaging and investigate the dose difference in the therapeutic regime. Methods Ten patients diagnosed with primary tumors of the cervical vertebra between 2013 and 2014 were enrolled. Prior to radiotherapy, the imaging data of MRI examination (GE Discovery MR 750 3.0T) were collected, transfered into the Eclipse system and subject to fusion with CT images. GTV delineation, organ at risk (OAR) delineation and dose distribution discrepancy induced by target volume differences were analyzed and statistically compared between the MRI-CT fusion and CT-based images. GTV delineation and dose parameters among different radiologists between two approches were analyzed by analysis of variance (ANOVA) and paired t-test. Non-normally distributed variables were analyzed by Wilcoxon rank-sum test. The reliability of intraclass correlation coefficient (ICC) was assessed. Results The GTVMRI-CT volume was larger compared with the GTVCT volume. The volume overlap index was 0.84±0.17.The cordMRI-CTvolume was significantly less than the cordCT volume (P=0.001). For 5 radiologists, the ICCMRI-CT was larger than ICCCT. The DmaxMRI-CT of the spinal cord was (46.00±1.09) Gy, significantly less than (52.39±1.34) Gy for the DmaxCT(P=0.014). Conclusions It is unlikely to miss the target delineation on MRI-CT fusion imaging. MRI-CT fusion imaging can minimize the discrepancy of interobserver radiologists and cause dosimetric advantages.
2018 Vol. 27 (5): 489-494 [Abstract] ( 970 ) [HTML 1KB] [ PDF 0KB] ( 0 )
495 Research on multi-leaf collimator fault prediction model of Varian Novalis Tx medical linear accelerator based on BP Neural Network realized by R language
Deng Yongjin, Xiao Zhenhua, Ouyang Bin, Wang Zhenyu, Huang Botian, Huang Jingxian, Bao Yong

Objective To construct and investigate the multi-leaf collimator (MLC) fault prediction model of Varian NovalisTx medical linear accelerator based on BP neural network. Methods The MLC fault data applied in clinical trial for 18 months were collected and analyzed. The total use time of accelerator, the quantity of patients per month, average daily working hours of accelerator, volume of RapidArc plans and time interval between accelerator maintenance were used as the input factors and the prediction of MLC fault frequency was considered as the output result. The BP neural network model of MLC fault prediction was realized by AMORE package of R language and the simulation results were validated. Results The model contained 3 layers of network to realize the input-output switch. There were 5 nodes in the input layer,13 nodes in the hide layer and 1 node in the output layer, respectively. The transfer function from the input layer to the hide layer selected the tansig function and purelin function was used from the hide layer to the output layer. The maximum time of training was pre-set as 150 in the designed model. Actually, 111 times of training were performed. The pre-set error was 3% and the actual error was 2.7%, which indicated good convergence. The simulation results of MLC fault applied in clinical trial for 18 months were similar to the actual data. Conclusions The BP neural network model realized by R language of MLC fault prediction can describe the mapping relationship between fault factors and fault frequency, which provides references for the understanding of accelerator fault and management of spare parts inventory.

2018 Vol. 27 (5): 495-499 [Abstract] ( 1016 ) [HTML 1KB] [ PDF 0KB] ( 0 )
500 Study of significance of head fixation in the chest wall field combined with supraclavicular field radiotherapy for breast cancer
Xie Tao, Xu Qing, Peng Jiayuan, Meng Yiran, Guan Shikuo, Yang Zhaozhi, Mei Xin, Yu Xiaoli

Objective To explore the importance of head fixation in chest wall field combined with supraclavicular field radiotherapy for breast cancer by comparing the displacement error and dosimetric differences caused by multi-functional body board and breast bracket. Methods Thirty patients with breast cancer were randomly divided into groups A and B. In group A, patients were fixed with multi-functional body board and head thermoplastic film. In group B, patients were fixed with traditional breast brackets. Each patient received CBCT scan before and after radiotherapy. Both setup errors and intra-fractional displacements in the x-,y-and z-axis, V100 and V95 were calculated. Statistical analyses were performed using the independent sample t-test. Results The displacement errors in groups A and B before and after radiotherapy were (1.24±0.42),(1.71±0.61) and (2.25±1.04) mm vs.(3.67±2.05),(3.78±1.74),(4.65±2.66) mm in the x-,y-and z-axis, respectively (P=0.033,0.027,0.020).The intra-fractional displacements in groups A and B were (1.10±0.66),(1.13±0.59),(1.11±0.62) mm vs.(2.48±0.88),(2.21±0.98),(3.53±2.01) mm in the x-,y-and z-axis, respectively (P=0.030,0.021,0.013).The V100 in groups A and B were (94.27±3.20)% and (99.08±0.60)%(P=0.065),and (89.48±4.70)% and (96.53±2.50)% for V95(P=0.002),respectively. Conclusion The risk of displacement error is significantly reduced using multi-functional body board, which enhances the accuracy of radiation dose in chest wall and supraclavicular fields of breast cancer patients.

2018 Vol. 27 (5): 500-503 [Abstract] ( 1118 ) [HTML 1KB] [ PDF 0KB] ( 0 )
504 Application and set-up error of deep inspiration breath-hold (DIBH) technique for whole breast irradiation in left breast cancer
Chen Siye, Wang Shulian, Tang Yu, Tian Yuan, Qin Shirui, Cui Weijie, Jin Jing, Liu Yueping, Song Yongchun, Fang Hui, Chen Bo, Qi Shunan, Zhang Jianghu, Sun Guangyi, Deng Yanbo, Li Yexiong

Objective To analyze the correlation between treatment time and radiotherapy plan of deep inspiration breath-hold (DIBH) technique for the whole breast irradiation (WBI) in the left breast cancer after breast-conserving surgery,verify the inter-fractional reproducibility of radiotherapy,observe the heart location and dosimetric changes and calculate the effect of DIBH upon the WBI setup error after the surgery. Methods We prospectively enrolled 15 patients with left breast cancer undergoing WBI after breast-conserving surgery,who met the requirement of DIBH.Treatment time was recorded,its correlation with the number of field and monitor unit was analyzed. Inter-fractional setup errors and PTV delineation were calculated using cone beam CT (CBCT).The accuracy of the position and dose of the heart during radiotherapy was verified by the imaging fusion of CBCT and CT images. The variables among groups were analyzed by non-parametric Firedman test. Results The average treatment time of DIBH radiotherapy was 4.6 minutes. The treatment time was correlated with the maximal and total number of sub-fields and total monitor units. During DIBH treatment,the mean cardiac displacement volume was 19.1 cm3(3.8%).The mean cardiac dose difference between CBCT and planning CT was 5.1 cGy,and there was no significant difference in the heart V5-V30.The mean inter-fractional system setup error (Σ) and random setup error (σ) in the left-right (x),superior-inferior (y) and anterior-posterior (z) direction were Σx 1.9 mm,Σy 2.1 mm,Σz 2.0 mm,σx1.3 mm,σy 1.3 mm,σz 1.4 mm,respectively. The corresponding minimal margins for setup error were 5.7 mm,6.2 mm and 6.0 mm,respectively. Conclusion DIBH for WBI after breast-conserving surgery does not significantly prolong the treatment time. Treatment time is related to treatment plan. DIBH yields high inter-fractional reproducibility and protects the heart.

2018 Vol. 27 (5): 504-508 [Abstract] ( 1138 ) [HTML 1KB] [ PDF 0KB] ( 0 )
509 Application of abdominal balloon compression combined with four-dimensional computed tomography in three-dimensional radiotherapy for non-small cell lung cancer
Zhao Yongliang, Xie Guodong, Jin Jianhua, Yang Xiaomei, Wu Jianting, Liu Haitao, Chu Kaiyue
Objective To compare the size of target volume, amplitudes of movements in different directions, movement vector, dose to the diseased lung, whole lung volume, and setup error between free breathing fixation (method A) and four-dimensional computed tomography (4DCT)-guided abdominal balloon compression fixation (method B), and to demonstrate that the 4DCT-guided abdominal balloon compression fixation is effective in the treatment of non-small cell lung cancer (NSCLC). Methods A retrospective analysis was performed among 80 patients with NSCLC in our hospital. In those patients, 40 received method A and 40 method B. The GTVfree and GTVpress were delineated on the maximum intensity projection (MIP) images of 10 respiratory phases using method A and method B, respectively. The PTVfree and PTVpress were obtained by expansion of the GTVfree and GTVpress, respectively. The paired t test was used to analyze the differences in the PTV, maximum amplitudes of movements in three dimensions, absolute value of the movement vector (|V|), and volume between method A and method B. The treatment planning system was used to compare the V5, V10, V20, and V30 of the diseased lung and the whole lung volume between method A and method B. All patients underwent cone-beam CT (CBCT) scans after positioning. Setup error was obtained by matching the CBCT images with the MIP images in the XVI system based on bone and grayscale values. Results The PTVfree and PTVpress were (283.2±12.74) and (201.8±12.99) cm3, respectively (P=0.002). The maximum amplitudes of movements in the right-left, superior-inferior, and anterior-posterior directions as well as the|V| value were (0.22±0.02),(1.85±0.08),(0.43±0.26), and (1.91±0.27) cm, respectively, for method A, and (0.05±0.01),(0.41±0.03),(0.16±0.16), and (0.44±0.16) cm, respectively, for method B (P=0.120, 0.001, 0.070). The V5, V10, V20, and V30 for the diseased lung and total lung volume were (61.26±4.27)%,(44.52±1.70)%,(28.22±3.13)%,(18.26±5.17)%, and (3556±223.12) cm3, respectively, for method A, and (52.74±4.78)%,(38.76±4.92)%,(23.71±4.03)%,(15.54±3.43)%, and (3376±311.65) cm3, respectively, for method B (P=0.001, 0.003, 0.004, 0.021, 0.004). There was no significant difference in setup error obtained by the XVI system between the two fixation methods (P>0.05). Conclusions Without increasing setup error, abdominal balloon compression can effectively control the lung movement amplitude, reduce the planning target volume, and reduce the radiation dose to the lung in patients with NSCLC.
2018 Vol. 27 (5): 509-512 [Abstract] ( 1055 ) [HTML 1KB] [ PDF 0KB] ( 0 )
513 Impacts of bladder and rectum filling status on their dosimetric parameters in helical tomotherapy for cervical cancer
Zhang Zongkai, Wang Yadi, Zhang Fuli, Lu Na, Yao Bo, Jiang Huayong
Objective To analyze the changes in volume and the planning volume of the bladder and rectum during helical tomotherapy (HT) treatment for cervical cancer, and to evaluate the impacts of bladder and rectum filling on their dosimetric parameters. Methods Twenty patients with cervical cancer who received HT in our hospital from 2012 to 2016 were enrolled as subjects. Before treatment, megavolt computed tomography (MVCT) and registration of planning CT images were preformed to recalculate the dose distribution, delineate the target volume, and measure the volume and position of the bladder and the rectum. Each MVCT image and the corresponding single dose were obtained by dose reconstruction using the Planned Adaptive module in HT planning workstation. The fused MVCT images and the corresponding single dose for each MVCT were loaded to MIM Maestro software 6.0 for dose stacking. The obtained total radiation dose was compared with that obtained by kilovolt CT. Between-group comparison was made by paired t-test or analysis of variance. Results If the volume change in the bladder was more than 400 ml or the rate of volume change was higher than 60%, the displacements of the bladder centroid toward the foot and dorsal sides were significantly increased;the Dmean and V50 were significantly increased (P<0.05). If the volume change in the rectum was more than 30 ml or the rate of volume change was higher than 30%, the displacements of the rectum centroid toward the head and ventral sides were significantly increased;the V45 and V50 for the rectum were significantly increased (P<0.05). Conclusions Although the bladder filling status has little effect on the radiation dose to the bladder,the volume change or the rate of volume change should be no more than 400 ml or 60%, respectively. Moderately filled bladder is recommended for positioning and treatment,which achieves satisfactory repeatability of the treatment. A volume change of more than 30 ml or a rate of volume change of higher than 30% can result in an increase in the dose to the rectum. Empty rectum can effectively reduce the dose to the rectum.
2018 Vol. 27 (5): 513-516 [Abstract] ( 1004 ) [HTML 1KB] [ PDF 0KB] ( 0 )
Review Articles
517 Research progress in intraoperative radiotherapy for tumor
Chen Zhishen, Fan Jiaojiao, Yu Lei, Jia Xiaojing
Intraoperative radiotherapy (IORT) is a radiotherapy method that uses a radiotherapy device to provide a brachytherapy with single high-dose radiation to a target tissue (primary tumor beds, residual tumors, and lymphatic drainage areas) during surgery, which includes intraoperative electron beam radiotherapy and high-dose-rate intraluminal brachytherapy. Nowadays, the implementation of precise radiation dose is an important part of multidisciplinary, individualized treatment of tumors. IORT achieves precise treatment by maximizing the radiation dose to the target volume and protecting surrounding normal tissues as much as possible. This article describes the recent research on IORT.
2018 Vol. 27 (5): 517-521 [Abstract] ( 974 ) [HTML 1KB] [ PDF 0KB] ( 0 )
522 Radiomics in the precision diagnosis and treatment of brain tumor:the application and challenge
Bai Long, Li Guangjun, Zhang Yuemei, Bai Sen

While emphasizing"Precision Medicine" nowadays, comprehending the specificity of patients and pathology is the key to achieving the precision diagnosis and treatment. Radiomics is a high-throughput quantitative analysis that combines the quantitative features from the region of interest on medical image and the biology and heterogeneity of tumor. It provides a non-invasive, convenient, dynamic, and quantitative method to collect the patient′s specific features of pathology and gene. Radiomics holds promise for the precision diagnosis and treatment of brain tumor. It can be used for molecular pathology diagnosis, definition of tumor boundaries, prognosis, prediction of complications, and so on. It helps to develop individualized measures for the prevention, diagnosis, treatment, and prognostic monitoring based on their disease features.

2018 Vol. 27 (5): 522-526 [Abstract] ( 1205 ) [HTML 1KB] [ PDF 0KB] ( 0 )
527 Treatment plan design of three-dimensional high-dose-rate brachytherapy for cervical cancer
Zhao Hongfu, Cheng Guanghui, Han Dongmei

The development of a treatment plan is one of the critical steps in the three-dimensional (3D) brachytherapy for cervical cancer. This article reviews more than 40 papers on the treatment plan design of high-dose-rate brachytherapy for cervical cancer and summarizes the principles and methods for developing a treatment plan of 3D brachytherapy. There are many difficult points in 3D brachytherapy. The doses delivered to tumor and normal tissues need to be balanced by considering many different factors under different conditions. In addition, there are still some uncertain factors for developing the treatment plan of 3D brachytherapy, which needs further exploration and research in the future. It can provide some references for colleagues in 3D brachytherapy for cervical cancer.

2018 Vol. 27 (5): 527-532 [Abstract] ( 840 ) [HTML 1KB] [ PDF 0KB] ( 0 )
533 Research progress in radiotherapy combined with immunotherapy for non-small cell lung cancer
Yuan Meng, Men Yu, Hui Zhouguang
Radiotherapy is the common traditional treatment for non-small cell lung cancer (NSCLC). In recent years, remarkable advances have been made in immunotherapy, especially the use of immune checkpoint inhibitors. How to effectively combine radiotherapy and immunotherapy to maximize the benefit for patients has become a hot topic in clinical research. This article expounds recent research progress in immunotherapy for NSCLC, the effect of radiotherapy on tumor immunology, and the advances and challenges in radiotherapy combined with immunotherapy for NSCLC.
2018 Vol. 27 (5): 533-537 [Abstract] ( 1218 ) [HTML 1KB] [ PDF 0KB] ( 0 )
Symposium
538 A review of updated guidelines for radiotherapy for primary liver cancer
Yang Yongqiang, Tian Ye

The treatment guidelines based on evidence-based medical evidence provide appropriate treatment strategies for clinical oncologists. Currently, many treatment guidelines for primary liver cancer have been published and updated by many organizations from different countries, including Barcelona Clinic Liver Cancer (BCLC), European Association for the Study of the Liver and European Organization for Research and Treatment of Cancer (EASL-EORTC), American Association for the Study of Liver Diseases (AASLD), National Comprehensive Cancer Network (NCCN), Asia-Pacific Primary Liver Cancer Expert (APPLE), Korean Liver Cancer Study Group and National Cancer Center (KLCSG-NCC), and Chinese Society for Therapeutic Radiology and Oncology (CSTRO), Chinese Medical Association. Although radiotherapy is commonly used in clinical practice, some guidelines do not accept it as a standard treatment strategy. In this article, we review the current treatment guidelines and discuss the current status and future prospects of radiotherapy in the management of primary liver cancer.

2018 Vol. 27 (5): 538-541 [Abstract] ( 758 ) [HTML 1KB] [ PDF 0KB] ( 0 )
中华放射肿瘤学杂志
 

News

 
·
·
More.....
 

Cooperation unit

 
  友 情 链 接  
 China Association for
 Science and Technology
 Chinese Medical Association
 Cancer Hospital of Chinese
 Academy of Medical
 Sciences Department of
 Radiation Oncology
 Chinese Anti-Cancer
 Association
 Chinese Journal of Lung
 Cancer
 Cqvp
 CNKI
 Wanfang Data
 More....  
 
  Copyright © 2010 Editorial By Chinese Journal of Radiation Oncology
Support by Beijing Magtech Co.ltd  support@magtech.com.cn